insights
Four ways life sciences companies are adapting to a COVID-19 world
The healthcare ecosystem is rapidly evolving in response to the COVID-19 pandemic. Last week, MATTER hosted a virtual roundtable with innovation leaders from eight leading pharmaceutical and medical device companies from across the world to compare notes about what they’re focused on today — and how they think the pandemic will affect the policies and norms that shape their business imperatives…